Results 171 to 180 of about 377,076 (351)

History and future technical innovation in positron emission tomography

Journal of Medical Imaging, 2017
T. Jones, D. Townsend
semanticscholar   +1 more source

Reply to “Clarifying the Moderating Role of Socioeconomic Status on Amyloid‐Related Gray Matter Atrophy”

Annals of Neurology, EarlyView.
Dario Bachmann, Valerie Treyer
wiley   +1 more source

Advances in radiopharmaceuticals for cancer radiotheranostics: CCK2R targeting as a paradigm for translational innovation

Cancer Communications, EarlyView.
Abstract Radiopharmaceuticals are reshaping the landscape of cancer therapy, offering a unique theranostic advantage that is becoming increasingly central to precision medicine. By labeling the same molecular scaffold with different radionuclides, these agents enable seamless integration of diagnostic imaging and targeted therapy.
Jing Li, Xuejun Wen, Rebeka Rita Reszegi, Hemavarshini Kamalrhaj, Wolfgang J. Parak, Xiaoyuan Chen, Jingjing Zhang   +6 more
wiley   +1 more source

Pulmonary Cryptococcosis With Rapid Growth on Positron Emission Tomography/Computed Tomography. [PDF]

Respirol Case Rep
Fukuda Y, Oda N, Sagara H, Tanaka A.
europepmc   +1 more source

Tau-positron emission tomography correlates with neuropathology findings

Alzheimer's & Dementia, 2019
V. Lowe, Emily S. Lundt, Sabrina M. Albertson, Hoon-Ki Min, Ping Fang, S. Przybelski, M. Senjem, C. Schwarz, K. Kantarci, B. Boeve, David T. Jones, R. Reichard, Jessica F. Tranovich, Fadi S Hanna Al-Shaikh, D. Knopman, C. R. Jack, Dennis W. Dickson, R. C. Petersen, M. Murray   +18 more
semanticscholar   +1 more source

Interactions of Neurodegenerative Disease Positron Emission Tomography Imaging Probe Candidates with the C‐Terminus of α‐Synuclein Fibrils

ChemBioChem, EarlyView.
Binding studies of α‐synuclein (αS) fibril ligands using photo‐crosslinking mass spectrometry and Förster resonance energy transfer show that the multiple system atrophy (MSA)‐selective lead, HY‐215, interacts with the αS C‐terminus, unlike Parkinson's disease (PD)‐selective lead, M503. Thus, often‐ignored interactions with the disordered regions of αS
Kyle D. Shaffer, Ryann M. Perez, Marshall G. Lougee, Vinayak V. Pagar, Hee Jong Kim, Ho Young Kim, Benjamin A. Garcia, Robert H. Mach, E. James Petersson   +8 more
wiley   +1 more source

Radiolabelled Cyclodextrins for the Positron Emission Tomography Imaging of Breast Cancer: Preclinical Perspectives. [PDF]

Clin Transl Sci
Sass T, Szabó JP, Dienes RA, Árkosy P, Opposits G, Jószai I, Fekete A, Fenyvesi F, Hajdu I, Trencsényi G, Képes Z.   +10 more
europepmc   +1 more source

The cerebral blood flow and metabolism for Broca's aphasia using positron emission tomography.

, 1987
Toshiaki Kato
openalex   +2 more sources

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures

Journal of Nuclear Cardiology, 2016
V. Dilsizian, S. Bacharach, R. Beanlands, S. Bergmann, D. Delbeke, S. Dorbala, R. Gropler, J. Knuuti, H. Schelbert, M. Travin   +9 more
semanticscholar   +1 more source

Biocompatible Chemistry: A Plug‐and‐Play Toolbox for Chemical Biology Research

ChemBioChem, EarlyView.
The “plug‐and‐play” nature of biocompatible chemistry makes it a powerful toolbox for investigating complicated biological systems and producing drug leads for clinical usages. This review summarizes the commonly used biocompatible reactions and the recent advances of their representative applications in chemical biology research, thus highlighting the
Adam R. Lovato, Zeng Lin, Qingfei Zheng
wiley   +1 more source